期刊文献+

腺苷预处理对行法洛四联症根治术婴幼儿的脑保护作用

Brain protection of adenosine preconditioning in infants undergoing radical correction for failot tetrad
原文传递
导出
摘要 目的探讨腺苷预处理对行法洛四联症(TOF)根治术婴幼儿的脑保护作用。方法将120例体外循环下行TOF根治术婴幼儿随机分为腺苷组和对照组,腺苷组在术前静脉滴注腺苷,总量为1.5mg/kg。分别于转流前及开放循环后30min、12h取静脉血,采用ELISA法测定血浆中神经组织蛋白质S-100β(S-100β蛋白)、神经元特异性烯醇化酶(NSE)水平。结果腺苷组主动脉开放后30min、12hS-100β为(0.346±0.162)和(0.541±0.272)μg/L,明显低于对照组(0.717±0.260)和(1.140±0.567)μg/L(均P〈0.001);腺苷组NSE为(10.43±5.54)和(15.54±7,98)μg/L,明显低于对照组(15.75±7.96)和(23.67±8.00)μg/L(均P〈0.001)。结论腺苷预处理可以降低TOF根治术婴幼儿血中S-10013和NSE,对脑组织具有良好的保护作用。 Objective To investigate the brain protection of adenosine preconditioning in infants with tetralogy of Fallot C TOF) undergoing open heart surgery. Methods 120 patients with TOF undergoing open heart surgery were randomly divided into two groups : adenosine group and control group. Total dosage of 1.5 mg/kg adenosine was intravenously dripped in the adenosine group before the cardiopulmonary bypass, Serum S-100β and neurone specific enolase C NSE) were measured before the cardipulminary bypass, 30 min and 12 hours after the aorta off clamping. Results At 30 min and 12 hour after opening the aorta, the S-100β[ (0.346 ±0, 162) μg/L vs. (0.717 ± 0.260)μg/L and (0,541 ± 0,272 )μg/L vs. ( 1,140 ± 0.567 ) μg/L,P 〈 0,001 ] and NSE [ ( 10, 43 ± 5.54) μg/L vs, ( 15.75 ±7.96) μg/L and (15.54 ±7.98)μg/L vs. (23, 67 ±8.00)μg/L,P 〈0.001 ]were both lower in adenosine group than that in control group. Conclusion Adenosine preconditioning can reduce the S-100β and NES in infants with TOF undergoing open heart surgery and has brain protection.
出处 《中国综合临床》 北大核心 2008年第8期749-750,共2页 Clinical Medicine of China
基金 基金项目:河北省科技厅技术攻关项目(052761246)
关键词 心脏直视手术 腺苷 婴幼儿 神经组织蛋白质S-100β 神经元特异性烯醇化酶 Open heart surgery Adenosine infant S-100β Neurone specific enolase
  • 相关文献

参考文献11

二级参考文献69

  • 1陶运明,莫绪明,彭卫,戚继荣,钱龙宝,顾海涛.深低温停循环对大脑皮层神经细胞凋亡的影响[J].现代医学,2004,32(3):187-189. 被引量:5
  • 2范文辉 郭艳萍 杜丽.急性缺血性脑血管病患者血浆S-100蛋白的初步研究[J].神经生化学通报,2000,13(1):61-61.
  • 3Taggart DP, Reece LI, Wheathy DJ. Cerebral deficit after cardiac surgery Lancet, 1987,1:47.
  • 4Borowicz LM, Goldsborough MA, Selnes OA, et al. Neuropsychological change after cardiac surgery: a critical review. J Cardiothorac Vasc Anesth, 1996, 10:105-111.
  • 5Nussmeier NA. Adverse neurologic events: risks of intracardiac versus extracardiac surgery. J Cardiothorac Vase Anesth, 1996, 10:31 - 37.
  • 6Gao F, Harris DN, Sapsed-Byrne S, et al. Neurone-specific enolase and sangtec 100 assay during cardiac surgery : part III-does haemolysis affect their accuracy? Perfusion,1997,12:171- 177.
  • 7Shsahan A, Harmer M, Vaughan R. Serum S100 protein as a marker of cerebral danage during cardiac surgery. Br J Anaesth,2000,85:287 - 298.
  • 8Johnson P, Lunqvist C, Lindberg A, et al. Cerebral complications after cardiac surgery assessed by S100 and NSE levels in blood. J Cardiothorac Vase Anesth, 1995,9:694- 699.
  • 9Wolfgang W, Markus T, Trampistch E, et al. Off-pump coronary bypass operations significantly reduce S100 release: an indicator for less cerebral damage? Ann Thorac Surg, 2000,70:1577 - 1579.
  • 10Taggart D, Mazel JW, Kausik B, et al. Comparison of S-100β levels during CABG and intracardiac operations. Ann Thorac Surg, 1997, 63: 492 - 496.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部